Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Laugel

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Therapie|December 17, 2022
Paediatric drug development and evaluation: Existing challenges and recommendationsFlorentia Kaguelidou, Maria Ouèdraogo, Jean-Marc Treluyer, et al.
American Journal of Medical Genetics. Part A|January 5, 2011
ARX polyalanine expansions are highly implicated in familial cases of mental retardation with infantile epilepsy and/or hand dystoniaMireille Cossée, Laurence Faivre, Christophe Philippe, et al.
Neuromuscular Disorders : NMD|November 28, 2017
Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysisSimone Schmidt, Patricia Hafner, Andrea Klein, et al.
Journal of Neuromuscular Diseases|July 8, 2025
REGISTRE SMA FRANCE: A nationwide observational registry of patients with spinal muscular atrophy in FranceLamiae Grimaldi, Rocio Garcia-Uzquiano, Marta Gomez-Garcia de la Banda, et al.
JAMA Network Open|October 8, 2025
Comparative Clinical Outcomes of Nusinersen and Gene Therapy in Spinal Muscular Atrophy Type 1Juliette Ropars, Claude Cances, Rocio Garcia-Uzquiano, et al.
Neurology|January 13, 2025
Safety and Efficacy of IV Onasemnogene Abeparvovec for Pediatric Patients With Spinal Muscular Atrophy: The Phase 3b SMART StudyHugh J McMillan, Giovanni Baranello, Michelle A Farrar, et al.
Pediatric Neurology|August 2, 2024
Copy Number Variation and Epilepsy: State of the Art in the Era of High-Throughput Sequencing-A Multicenter Cohort StudySarah Baer, Audrey Schalk, Marguerite Miguet, et al.
Annals of Clinical and Translational Neurology|December 28, 2020
Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA studyMélanie Annoussamy, Andreea M Seferian, Aurore Daron, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe PhenotypeLaurent Servais, Marie Montus, Caroline Le Guiner, et al.
Therapie|January 1, 2026
Accelerating recruitment in clinical trials: A strategic challengeDominique Deplanque, Ariane Galaup, Christine Trillou, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Therapie|December 17, 2022
Paediatric drug development and evaluation: Existing challenges and recommendationsFlorentia Kaguelidou, Maria Ouèdraogo, Jean-Marc Treluyer, et al.
American Journal of Medical Genetics. Part A|January 5, 2011
ARX polyalanine expansions are highly implicated in familial cases of mental retardation with infantile epilepsy and/or hand dystoniaMireille Cossée, Laurence Faivre, Christophe Philippe, et al.
Neuromuscular Disorders : NMD|November 28, 2017
Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: A cross-sectional analysisSimone Schmidt, Patricia Hafner, Andrea Klein, et al.
Journal of Neuromuscular Diseases|July 8, 2025
REGISTRE SMA FRANCE: A nationwide observational registry of patients with spinal muscular atrophy in FranceLamiae Grimaldi, Rocio Garcia-Uzquiano, Marta Gomez-Garcia de la Banda, et al.
JAMA Network Open|October 8, 2025
Comparative Clinical Outcomes of Nusinersen and Gene Therapy in Spinal Muscular Atrophy Type 1Juliette Ropars, Claude Cances, Rocio Garcia-Uzquiano, et al.
Neurology|January 13, 2025
Safety and Efficacy of IV Onasemnogene Abeparvovec for Pediatric Patients With Spinal Muscular Atrophy: The Phase 3b SMART StudyHugh J McMillan, Giovanni Baranello, Michelle A Farrar, et al.
Pediatric Neurology|August 2, 2024
Copy Number Variation and Epilepsy: State of the Art in the Era of High-Throughput Sequencing-A Multicenter Cohort StudySarah Baer, Audrey Schalk, Marguerite Miguet, et al.
Annals of Clinical and Translational Neurology|December 28, 2020
Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA studyMélanie Annoussamy, Andreea M Seferian, Aurore Daron, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe PhenotypeLaurent Servais, Marie Montus, Caroline Le Guiner, et al.
Therapie|January 1, 2026
Accelerating recruitment in clinical trials: A strategic challengeDominique Deplanque, Ariane Galaup, Christine Trillou, et al.
Pageof 12